Zacks Investment ResearchFri, 27 Mar 2026 13:51:11 GMTKaryopharm Therapeutics (KPTI) Stock Jumps 6.9%: Will It Continue to Soar?KPTI-2.37%
Zacks Investment ResearchWed, 25 Mar 2026 15:26:10 GMTKPTI Stock Down on Mixed Phase III Myelofibrosis Combo Study DataKPTI-2.37%
Seeking AlphaTue, 24 Mar 2026 18:54:50 GMTKaryopharm Therapeutics Inc. (KPTI) Discusses Top Line Results From Phase III SENTRY Trial in Myelofibrosis TranscriptKPTI-2.37%
BenzingaTue, 24 Mar 2026 17:20:44 GMTKaryopharm Therapeutics Falls As Pivotal Trial Hits Spleen Goal But Misses Symptom MarkKPTI-2.37%
Zacks Investment ResearchWed, 18 Feb 2026 15:55:17 GMTWall Street Analysts Believe Karyopharm Therapeutics (KPTI) Could Rally 56.06%: Here's is How to TradeKPTI-2.37%
Seeking AlphaThu, 12 Feb 2026 23:14:27 GMTKaryopharm Therapeutics Inc. (KPTI) Q4 2025 Earnings Call TranscriptKPTI-2.37%
Zacks Investment ResearchThu, 12 Feb 2026 14:46:15 GMTKaryopharm Therapeutics (KPTI) Reports Q4 Loss, Tops Revenue EstimatesKPTI-2.37%
